HYO

[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate

Created: 2020-01-02
Last modified:  2020-03-18

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count44
Chiral Atom Count4
Bond Count46
Aromatic Bond Count6
2D diagram of HYO
Toggle HydrogenToggle Labels

Chemical Component Summary

Name[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate
Systematic Name (OpenEye OEToolkits)[(1~{R},5~{S})-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2~{S})-3-oxidanyl-2-phenyl-propanoate
FormulaC17 H23 N O3
Molecular Weight289.369
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESCACTVS3.385CN1[CH]2CC[CH]1C[CH](C2)OC(=O)[CH](CO)c3ccccc3
SMILESOpenEye OEToolkits2.0.7CN1C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3
Canonical SMILESCACTVS3.385 CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c3ccccc3
Canonical SMILESOpenEye OEToolkits2.0.7 CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3
InChIInChI1.03 InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16-/m1/s1
InChIKeyInChI1.03 RKUNBYITZUJHSG-FXUDXRNXSA-N

Drug Info: DrugBank

DrugBank IDDB00424 
NameHyoscyamine
Groups approved
DescriptionHyoscyamine is a tropane alkaloid and the levo-isomer of [atropine].[A228423] It is commonly extracted from plants in the _Solanaceae_ or nightshade family.[A228423] Research into the action of hyoscyamine in published literature dates back to 1826.[A228713] Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties.[L31548,L31553] Although hyoscyamine is marketed in the United States, it is not FDA approved.[L31548,L31553]
Synonyms
  • Tropine-L-tropate
  • Hyoscyamine sulfate dihydrate
  • L-Tropine tropate
  • (−)-atropine
  • Hyoscyamine hydrobromide
Brand Names
  • Urimar-T Caps
  • HyoMax-SL
  • Hyoscyamine S L
  • Belladonna Alkaloids with Phenobarbital
  • Hyoscyamine Sulfate Drops
IndicationAs a drug that is not FDA approved, hyscyamine has no official indications.[L31548,L31553] Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic.[L31548] Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation.[L31548] Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.[L31553]
Categories
  • Adjuvants, Anesthesia
  • Agents producing tachycardia
  • Alimentary Tract and Metabolism
  • Alkaloids
  • Anti-Asthmatic Agents
ATC-Code
  • A03BA03
  • A03CB31
CAS number101-31-5

Drug Targets

NameTarget SequencePharmacological ActionActions
Muscarinic acetylcholine receptor M1MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISF...unknownantagonist
Muscarinic acetylcholine receptor M2MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKV...unknownantagonist
Muscarinic acetylcholine receptor M3MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFS...unknownantagonist
Muscarinic acetylcholine receptor M4MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGN...unknownantagonist
Adenylate cyclase type 1MAGAPRGGGGGGGGAGEPGGAERAAGTSRRRGLRACDEEFACPELEALFR...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSD BIHWEX, WALPIJ